BeOne Medicines Ltd.ONC

Market cap

$429.5B

P/E ratio

	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	88	240	713	618	1,382	4,376	3,870	3,172	2,627
Accounts receivable, net	-	29	41	71	60	483	173	358	676
Inventory, Net	-	11	16	29	89	243	282	416	495
Prepaid expenses and other current assets	6	36	82	90	160	270	217	243	193
Total current assets	374	913	1,944	1,173	4,961	7,614	5,207	4,203	3,992
Property, Plant and Equipment, Net	26	63	157	242	358	588	846	1,324	1,578
Operating lease right-of-use assets	-	-	45	83	91	117	110	95	139
Intangible assets, net	-	7	7	6	5	47	41	57	51
Other non-current assets	5	43	54	68	113	163	170	125	160
Total non-current assets	31	133	306	440	640	1,032	1,172	1,602	1,929
Total assets	406	1,046	2,250	1,612	5,601	8,646	6,379	5,805	5,921
Accounts payable	12	70	113	122	232	262	295	315	405
Accrued Liabilities, Current	-	-	-	164	346	558	467	694	804
Tax payable	1	9	6	13	20	21	25	23	26
Operating Lease, Liability, Current	-	-	-	11	14	22	24	22	18
Research and development cost share liability, current portion	-	-	-	-	128	121	114	68	111
Short-term debt	-	9	9	-	-	428	329	688	852
Total current liabilities	35	150	246	310	1,075	1,600	1,469	1,810	2,215
Long-term debt	-	9	41	83	184	202	209	198	166
Operating Lease, Liability, Noncurrent	-	-	-	26	29	43	35	22	44
Deferred tax liabilities	-	-	11	11	11	14	16	16	42
Research and development cost share liability, non-current portion	-	-	-	-	375	270	180	171	54
Other long-term liabilities	1	32	39	47	57	54	46	51	67
Total non-current liabilities	18	212	250	324	656	803	527	458	374
Total liabilities	53	362	496	634	1,732	2,403	1,996	2,268	2,589
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0
Additional paid-in capital	591	1,001	2,745	2,926	7,415	11,191	11,541	11,599	12,088
Accumulated other comprehensive loss	-1	-0	2	-8	7	18	-77	-99	-149
Accumulated deficit	-237	-331	-1,007	-1,956	-3,553	-4,966	-7,080	-7,962	-8,607
Total shareholders’ equity	353	684	1,754	978	3,869	6,243	4,383	3,537	3,332
Total liabilities and shareholders’ equity	406	1,046	2,250	1,612	5,601	8,646	6,379	5,805	5,921